NUAK1 and inflammatory bowel disease: According to the manufacturer, OST-122 is an oral, gut-restricted, and subtype-selective JAK3/TYK2/AMPK-related protein kinase 5 (ARK5) inhibitor for the local treatment of IBD including UC, CD and, potentially, fibrotic lesions in Crohn’s patients [38].